Former CytoDyn CEO and clinical trial associate indicted for defrauding investors by Charlotte Schubert on December 21, 2022December 21, 2022 at 1:21 pm The U.S. Department of Justice will prosecute the former CEO of Vancouver, Wash.-based biotech company CytoDyn, Nader Pourhassan, and an associate for allegedly defrauding investors. Pourhassan and Kazem Kazempour, CEO… Read More